Quick answers
- What is Potassium phosphates used for?
- The FDA-approved label (Potassium Phosphates, Civica, Inc., July 10, 2026) says: “Potassium Phosphates Injection is indicated as a source of phosphorus: • in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. • for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Potassium phosphates have a boxed warning?
- No. None of the 7 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Potassium phosphates?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Potassium phosphates been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Potassium phosphates?
- 6 companies list prescription products of Potassium phosphates in the FDA NDC Directory, including Fresenius Kabi USA, LLC, Glenmark Pharmaceuticals Inc., USA and Cipla USA Inc..
What Potassium phosphates is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Potassium Phosphates Injection is indicated as a source of phosphorus: • in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. • for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated. …
— FDA label: Potassium Phosphates, Civica, Inc., effective July 10, 2026. Read the full label on DailyMed →
The FDA has 7 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 7 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Injection, solution, concentrate · Injection, solution · Injection |
|---|---|
| Route | Intravenous |
| Prescription products | 15 in the FDA NDC Directory |
| Brand names | Potassium Phosphates |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Fresenius Kabi USA, LLC5 products
- Glenmark Pharmaceuticals Inc., USA3 products
- Cipla USA Inc.3 products
- Somerset Therapeutics, LLC2 products
- Hospira, Inc.1 product
- Civica, Inc.1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA212832 POTASSIUM PHOSPHATES, POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE | Fresenius Kabi USA | November 26, 2019 | 1, latest August 30, 2024 2024: Manufacturing (CMC) |
Generic approvals (4)
- ANDA217726Somerset Theraps LLC · July 11, 2024
- ANDA217892Cipla · January 24, 2025
- ANDA217459Hospira · September 11, 2025
- ANDA220373Caplin · March 12, 2026
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Potassium Phosphates, Civica, Inc., effective July 10, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →